#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency common variable Hepatitis B Neuroblastoma recurrent Chemical burn Craniocerebral injury Duchenne muscular dystrophy Anal cancer recurrent Homocystinuria B-cell small lymphocytic lymphoma Restless legs syndrome Stiff person syndrome Chronic myeloid leukaemia Oesophageal atresia Vernal keratoconjunctivitis Acute hepatic failure More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Diagnostics Alexander disease – Life with Disease Usher’s syndrome Glycogen storage disease type V – Treatment X-linked lymphoproliferative syndrome – Diagnostics Undifferentiated sarcoma – Diagnostics Chordoma – Treatment Primary immunodeficiency syndrome – Treatment Propionic acidaemia – Basic Information Waldenstrom’s macroglobulinaemia refractory – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Star-0215 Mva-209-Fsp-B1 Regn7508 Dexchlorpheniramine Maleate Bempikibart Avapritinib Ruxotemitide Macrogol 3350 Tafamidis Sym024 Patiromer Furosemide Ph. Eur. Niraparib Tosilate Monohydrate Theophylline Baricitinib Salmeterol Xinafoate Arachis Hypogaea Extract Etrasimod Arginine Av-Ec2023 Ethinylestradiol More therapies…

    Learn about Your Condition

    Apheresis Primary hypogonadism Breast angiosarcoma Double hit lymphoma Aplastic anaemia Body mass index increased Dermatitis Thermal burn Myocarditis post infection Caesarean section Methylmalonic acidaemia Andersen-Tawil syndrome Pulmonary fibrosis Impaired gastric emptying Choroidal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn’s Disease After Inadequate Response to Other Treatments

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Obefazimod
    Belgium Czechia France Germany Hungary Italy +5

  • Study on Reducing Bleeding Risk in Fibroid Surgery Using Misoprostol for Patients Undergoing Myomectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Uterine leiomyoma
    Investigated Drugs:
    • Misoprostol
    • Placebo
    France

  • Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Testicular seminoma (pure) stage I
    Investigated Drugs:
    • Bleomycin
    • Carboplatin
    • Cisplatin
    Norway Sweden

  • Study Comparing Oral Amoxicillin to Outpatient IV Antibiotics for Patients with Infective Endocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Investigated Drugs:
    • Amoxicillin
    Spain

  • Study on Oxytocin and Mindfulness Training for Reducing Stress in Adults with Psychological Distress

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study of TCR-Modified T Cell Therapy with ANOC-001, ANOC-002, and ANOC-003 for Adults with Advanced Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • ANOC-001
    Denmark Germany The Netherlands Sweden
Previous Page
1 … 257 258 259 260 261 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!